The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia.

The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia.

<h4>Background</h4>Sofosbuvir and ledipasvir-sofosbuvir are both newer direct-acting antiviral agents for the treatment of hepatitis C. The high list prices for both drugs have led to concern about the budget impact for public drug coverage programs. Therefore, we studied the impact of p...

Full description

Bibliographic Details
Main Authors: Harriet Ho, Naveed Z Janjua, Kimberlyn M McGrail, Mark Harrison, BC Hepatitis Testers Cohort Team, Michael R Law
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247843

Similar Items

Similar Items